Our Senior Associate, Girish Bhatia, recently attended a speed networking session organized by INTA, providing a fantastic opportunity to connect with colleagues from various jurisdictions worldwide. The session was thoughtfully structured to foster meaningful conversations and knowledge exchange among professionals from diverse backgrounds. Beyond discussing professional matters, what truly stood out was the opportunity to…
I.A. 7635/2024 and I.A. 46685/2024IN C.O.(COMM.IPD-PAT) 38/2022 Background The Petitioner, Macleods Pharmaceuticals Ltd., is engaged in manufacturing and marketing diverse pharmaceutical products, including anti-diabetic drugs. The Respondent no. 2, Boehringer Ingelheim Pharma GmbH & Co. KG, is a company organized under the laws of Germany and is involved in developing, manufacturing, and marketing pharmaceuticals worldwide,…
In the latest episode of Stories of Change Podcast, Ms. Rachna Bakhru shared insights on Intellectual Property Rights being often overlooked in the social sector. Nonprofits use Intellectual Property such as logos and donor databases. You can listen to the podcast here.
Shabnam Khan attended the Assocham Special Session on Fuelling Growth of the Indian Startup Ecosystem held on 15 Jan 2025 in New Delhi. The keynote was delivered by Mr. Satya Prakash Singh, Chief General Manager of SIDBI, who shared valuable insights on the role of purpose and vision in driving startup growth in India.
The Delhi High Court has ruled in favor of Opella Healthcare Group (“Petitioner”) in its bid to protect its mark “PHENSEDYL.” The dispute revolved around the Respondent’s (Vaibhav) mark “PHENSERYL” and its associated artistic work, which the Petitioner argued were deceptively similar to their well-known trademark. The Petitioner has also obtained an injunction from the…
ATAL Online 6 Day Faculty Development Programme 2024-25 organized successfully with active participation of more than 110 candidates from 25 States. Suvarna Pandey shared insights on Effective Innovation Management in Agriculture and Life Sciences.
The case highlights that apart from claims of ‘trade secrets’ and ‘confidential information’ the attorneys working with a law firm are bound by attorney client communication being privileged and cannot be divulged to a third party under any circumstances. Sharing such information and communication would not only be unethical but also a breach of the…
Zydus Healthcare Ltd. (“Zydus”) and Alder Biochem Pvt. Ltd. (“Alder”) are at loggerheads over the mark BIOCHEM. Zydus brought trademark infringement and passing-off lawsuit against Alder’s use of the mark ALDER BIOCHEM as its trade name. Zydus alleged that a) Alder’s use violated its intellectual property rights over the trademark BIOCHEM b) Alder’s adoption of…
Mr. Abhishek Nangia shared insights, strategies and anecdotes on the topic: Trademark Tales: Defending Brands and Futures. Listen to the full episode here.
Facts and Background The Plaintiffs, AstraZeneca, filed a suit (CS (Comm.) 101/2022) at the Delhi High Court seeking a permanent injunction to restrain the Defendant, Westcoast Pharmaceutical Works Limited from infringing their patent IN 297581. The Patent was for the novel compound Osimertinib, used for treating specific types of non-small cell lung cancer. In January…
